![Michael Smolinski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Smolinski
Nessuna posizione attualmente
Storia della carriera di Michael Smolinski
Precedenti posizioni note di Michael Smolinski
Società | Posizione | Inizio | Fine |
---|---|---|---|
ATHENEXPAR | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | 01/05/2022 |
Homecare Homebase LLC
![]() Homecare Homebase LLC Packaged SoftwareTechnology Services Homecare Homebase LLC provides enterprise management software to clients in the healthcare industry. It offers cloud-based solutions for data exchange, communications, claims processing, billing, and logistics, as well as systems implementation, training, and technical support services. The company was founded by April K. Anthony in 1999 and is headquartered in Dallas, TX. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Michael Smolinski
State University of New York at Buffalo | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Technology Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Homecare Homebase LLC
![]() Homecare Homebase LLC Packaged SoftwareTechnology Services Homecare Homebase LLC provides enterprise management software to clients in the healthcare industry. It offers cloud-based solutions for data exchange, communications, claims processing, billing, and logistics, as well as systems implementation, training, and technical support services. The company was founded by April K. Anthony in 1999 and is headquartered in Dallas, TX. | Technology Services |
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Borsa valori
- Insiders
- Michael Smolinski
- Esperienza